Member Info for Safy

oxford vaccine news today

Oxford vaccine results due today, 99% efficacy from phase II data. Hence the question.

Weekly antibody tests?

I’ve had it confirmed with Mologic it’s TWO tests.

Research shows doing two tests is more accurate than doing one antigen test. That’s what the ICMR tender stated too.

Fig

It’s ok I know what happens for Covid testing but I’m trying to understand what the approach has been so far.

Hi,

You mentioned your partner is undergoing trials for the Oxford vaccine.

How many antibody tests has your partner undertaken so far?

This isn’t a ramp or trick question, in data science when they do population measures, they don’t literally test the whole population, but instead they measure X number of responses and then do a calculation which gives projections across the population.

This is how they would determine how many tests they would need. At least if the same principles are applied that’s how I think they could / would do it.

Clearly 5% of the targeted vaccine candidates wouldn’t get the immunity because it doesn’t work for everyone... so that’s still an awful lot of people without immunity. So how do they check?

So in my head at the absolute minimum they would do one test per person to check if there is an immune response but I’m trying to understand from a real world scenario how many actual antibody tests they are currently doing, if any.

It won’t drop on no RNS. If it does it’ll be minimal. I’ll stick my neck out here. They have stickier hands.

Not to be confused with me going all Avacta :)

In some ways if some loose traders did leg it from ODX and get locked there, in the words of Kevin Keegan.... I’d love it. We definitely need to loose some slippy fingers.

Until our core share holder base isn’t corrected from day traders to sticky hands, and until EVERY NEWS isn’t leaked on Twitter and actually comes in the form on an RNS nothing significant will change here.

tbh i saw it at 9% up, i just thought pnd as usual, so did everyone on their forum.

they still dont know why its gone up, but tbf to them they deserve it, all covid stocks do. Weve been hammered by dodgy mm's and it seems they have been the beneficiary of dodgy mm's today.

there was no resistence on the way up, just kept going on avg pi trades.

avacta dont do speeding tickets, its only ODX

Without making the link to Oxford, there is a subtle implication that this was Abingdon's innovation....

Trilla, can you explain more please?

Thanks Regulator

Regulator

Have you read anywhere that the vaccine might give varied immune responses in different people?

Can you see a scenario where if someone vaccinated has the sniffles / cough, then their GP would at the first instance ask them to do an Antibody test?

Does the prospectus state what the Abi capacity is?

merchant

any guesses what price it could list at?

So I spoke to my broker today and the only information they have is you need to be a professional investor to be considered (500k in your account and having conducted X trades each quarter for one year) they want 20m if I remember correctly which is in line with what MB said.

They don’t think it’s imminent unless someone goes all in with the 20m because the details they have are minimal, and his view was if it was imminent they would have more details.

With regards to price they have no idea and nor do I because I have no experience in that area.

ODX for me is the better company hands down because we have different revenue streams post covid. However covid buyers could look as Abingdon as a primary covid pure play for short term gains and try to buy there.

I’m just going to throw something out there, AbC is important for ODX, more so with Ciga tweet, however some may argue that Mologic antigen LFT is more important or at least on par with AbC. CK certainly thinks so, just have a look at the presentation slide decks at capacity breakdown.

Feck knows what going to happen with AbC short term as there is a lot of negative publicity around that test, however the key thing to remember here is our bulk manufacturing is Mologic antigen LFT NOT AbC. So any negative press sticks to Abingdon more than it does us. And that could put off new ii investors there, certainly until this blows over.

The press seem to be going after gov in a big way, and in many cases rightfully so, there is a story in the news today about someone earning millions by being a middle man selling ppe and getting repeat contract without tender.

Well written article

I’m still not happy why they can’t write that the test measures antibodies and NOT prior infections.

We seem to be getting compared like apples n oranges.

Knightrider

I’m not sure how long you’ve been on this board, but I think my contribution to GDR far outweighs yours and that’s without me even having read a single one of your posts. The old crew know that full well.

I am not deramping. I wrote in block caps to avoid confusion so please learn to read before you go off on one.

The ones that know me will find some comfort reading what I wrote and that is clearly evident. The ones that don’t like what I wrote can skip and move on to the next thread.

Dave77

I think most people appreciated my post.

I have not told anyone to buy ODX nor have I endorsed it here. In fact I wrote don’t buy anything.

If that much in block capitals doesn’t register with you then I’m really not sure what to say.

Forgot to add, get your confidence back. It takes a while and frankly the fear of getting into unfamiliar territory is indeed stressful and sometimes can be perceived and being more stressful than sitting around and accepting what’s happening around you.

Not to be confused with me saying anyone should sell out. That’s not what my post is about.